This is the authors' abstract. We don't add key points for this paper.
Herein, we first present synthesis, structures, luminescent properties, and electrochemistry of gold(III)‐N‐heterocyclic carbene (NHC) complexes fasten with 2,2′‐bipyridine (bpy) or 1,10′‐phenanthroline (phen). Starting from the proligand 3‐[pyridin‐3‐yl]imidazo[1,5‐a]pyridin‐4‐ylium hexafluorophosphate (1·HPF6), two novel complexes, namely, [Au(1)(bpy)Cl][PF6]2 (2) and [Au(1)2(phen)][PF6]3 (3), have been synthesized and characterized by several spectroscopic techniques. Finally, the solid‐state structures of 2, 3, and precursors [Au(bpy)Cl2][PF6] and [Au(phen)Cl2][PF6] have been determined by single‐crystal X‐ray diffraction studies. The absorption, emission, and lifetime properties of 2 and 3 have been compared with the precursors [Au(bpy)Cl2][PF6] and [Au(phen)Cl2][PF6] to observe the influence of NHC. Though the precursors [Au(bpy)Cl2][PF6] and [Au(phen)Cl2][PF6] are non‐luminescent, yet complexes 2 and 3 are luminescent. A combination of the chromophoric and π‐acid bpy/phen ligand in Au(III) complexes with the strong σ‐donor NHC ligand significantly enhanced the emission properties of the complexes. The blue emission of 2 and 3 in 390–500 nm regions has been tentatively ascribed to arise from intraligand and metal‐to‐ligand charge transfer (MLCT) transitions; also, partial contributions are expected from hydrogen‐bonding interactions. Cyclic voltammetric studies revealed Au(III) → Au(I) and Au(I) → Au(0) reductions at ~ −0.35 to ‐0.29 V and ~ −1.20 to ‐1.15 V, and the potentials are compared with precursors.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Maity et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: